geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Efficacy of lapatinib in patients with high tumor EGFR expression: Results of a phase III trial in advanced renal cell carcinoma (RCC)


, : Efficacy of lapatinib in patients with high tumor EGFR expression: Results of a phase III trial in advanced renal cell carcinoma (RCC). Journal of Clinical Oncology 24(18_suppl): 4502-4502

NlmCategory="UNASSIGNED">4502 Background: Lapatinib is an orally-active, reversible inhibitor of EGFR/ErbB2 tyrosine kinases. In Phase I/II trials, lapatinib has demonstrated activity in patients (pts) with advanced breast cancer. We report the first results of a randomized open-label Phase III trial ( EGF20001 ) of lapatinib vs. hormone therapy (HT) in pts with advanced RCC that express EGFR and/or ErbB2 by immunohistochemistry (IHC). The main endpoints were time to progression (TTP) and overall survival (OS). Pts with advanced RCC of any histology who had failed first-line cytokine therapy were stratified by Karnofsky performance score (KPS) and number of metastatic sites. Pts were randomized to receive oral lapatinib 1250 mg OD or HT. The primary efficacy endpoint was TTP, with 90% power to detect a 50% increase (i.e. 4 vs. 6 months) at a two-sided 5% significance level. All pt scans were interpreted by independent radiologic review. At the time of the TTP analysis, 417 pts were randomized and 298 TTP events were reported. Demographic and baseline characteristics were similar between both arms; pooled results were: median age: 61 yrs; Stage IV disease: 97%, KPS 90-100: 59%, metastatic sites >2: 49%, prior nephrectomy: 94%, prior interferon therapy: 64%. No unexpected toxicities were observed, and drug-related AE (all grades) for lapatinib vs. HT included rash (44%:3%), diarrhoea (40%:3%). When results from all pts were analysed, median TTP was 15.3 weeks for lapatinib vs. 15.4 weeks for HT (hazard ratio (HR) = 0.94; p = 0.60), and median OS was 46.9 weeks for lapatinib vs. 43.1 weeks for HT (HR=0.88; p=0.29). In the major subgroup of 241 pts with EGFR overexpressed disease (3+ by IHC), median TTP was 15.1 weeks for lapatinib vs. 10.9 weeks for HT (HR = 0.76; p = 0.06), and median OS was 46.0 weeks for lapatinib vs. 37.9 weeks for HT (HR = 0.69; p = 0.02). These results were confirmed by Cox Regression analysis, and additional biomarker evaluation, including FISH, is underway. The EGFR/ErbB2 dual targeted inhibitor, lapatinib, appears to prolong overall survival compared to hormone therapy in advanced RCC pts with overexpressed EGFR who failed prior therapy. [Table: see text].

US$29.90

PMID: 27951840


Other references

Vatn, T.; Nordland, P., 1997: Birth weight in Norwegian Red calves. Data on 853 Norwegian Red calves in 24 herds, born in 1994-96, were analysed. Birth weight averaged 39.8 kg (41.2 and 38.1 kg respectively for males and females). Gestation length averaged 281.2 days; it was significantly shorter (by 1.5 days) for...

Duer, W.C.; Ogren, P.J.; Meetze, A.; Kitchen, C.J.; Von Lindern, R.; Yaworsky, D.C.; Boden, C.; Gayer, J.A., 2008: Comparison of ordinary, weighted, and generalized least-squares straight-line calibrations for LC-MS-MS, GC-MS, HPLC, GC, and enzymatic assay. The impact of experimental errors in one or both variables on the use of linear least-squares was investigated for method calibrations (response = intercept plus slope times concentration, or equivalently, Y = a(1) + a(2)X ) frequently used in ana...

Copeland, J.G., 2014: Philology, or what's the good word?. Missouri Medicine 111(5): 366-368

Mirkhodzhaev A.K., 1973: State of the hepato biliary system in patients with acromegaly. Problemy Endokria 19(3): 26-28

Jules, E.S., 1997: Consequences of forest fragmentation for the understory plant, Trillium ovatum (Liliaceae). The effects were studied of forest fragmentation in the Siskiyou Mountains of southwestern Oregon on a perennial herb, Trillium ovatum (western trillium), for which the ages of individual plants can be estimated. Surveys of tree plantations in are...

Mann, C.V.; Greenwood, R.K.; Ellis, F.H., 1964: The Esophagogastric Junction. Surgery, Gynecology & Obstetrics 118: 853-862

Georgieff M.; Moldawer L.L.; Wagner D.; Geiger K.; Fekl W.; Blackburn G.L.; Bistrian B.R.; Lutz H., 1987: Metabolism oriented posttraumatic nutritional support possibilities and limitations of the use of glucose and xylitol. Infusionstherapie und Klinische Ernaehrung - Forschung und Praxis 14(SUPPL 1): 53-64

Sanchez-Griñan, M.I.; Peerson, J.M.; Brown, K.H., 1992: Effect of dietary energy density on total ad-libitum energy consumption by recovering malnourished children. Clinical trials were conducted to measure the effect of dietary energy on total daily energy intakes by nine hospitalized young children recovering from protein-energy malnutrition. Semi-solid mixed diets containing either 50 or 100 kcal/100 g wer...

Arakaki, M.A.iyoshi, T., 1977: Effects of the autoxidized oils on lipid metabolism and drug metabolizing enzyme system in rats. Journal of the Food Hygienic Society of Japan: 18 (5) 474-480

Goldenberg, R.L.; Davis, R.O.; Brumfield, C.G., 1984: Transient fetal anuria of unknown etiology: a case report. American Journal of Obstetrics and Gynecology 149(1): 87-87